Join Now

CancerVax Targets Liver Cancers to Further Showcase Flexibility of Its Universal Platform

Using AI machine learning, the Company discovers distinct biomarkers for detecting certain rare liver cancers that have stem cell characteristics and will include them as additional indications in its preclinical program

Posted in BioUtah News | Tagged | Comments Off on CancerVax Targets Liver Cancers to Further Showcase Flexibility of Its Universal Platform

CancerVax Scientists Featured on Cytiva’s “Discovery Matters” Podcast Discussing Universal Cancer Vaccine Platform

Dr. George Katibah and Dr. Adam Grant describe the features and progress of the Company’s revolutionary technology

Posted in BioUtah News | Tagged | Comments Off on CancerVax Scientists Featured on Cytiva’s “Discovery Matters” Podcast Discussing Universal Cancer Vaccine Platform

CancerVax Passes First Test with Flying Colors

Recent in-vitro lab results confirm that the Company’s Smart mRNA can be used as a potential on/off switch for selectively detecting cancer cells

Posted in BioUtah News | Tagged | Comments Off on CancerVax Passes First Test with Flying Colors

CancerVax Targets Hard to Treat Pancreatic Cancer

With limited options available to treat Pancreatic Ductal Adenocarcinoma (PDAC), the Company’s Universal Cancer Treatment Platform may provide hope for patients and doctors

Posted in BioUtah News | Tagged | Comments Off on CancerVax Targets Hard to Treat Pancreatic Cancer

CancerVax Successfully Uses Nobel Prize Chemistry to Achieve Universal Cancer Vaccine Targeting Milestone

The UCLA research team created a low cost and customizable lipid nanoparticle using “click chemistry” for precise targeting of cancer cell surface markers

Posted in BioUtah News | Tagged | Comments Off on CancerVax Successfully Uses Nobel Prize Chemistry to Achieve Universal Cancer Vaccine Targeting Milestone

CancerVax Announces Promising New Drug to Treat a Deadly Children’s Cancer

Company plans to launch FDA IND enabling studies needed to apply for approval to proceed with human trials

Posted in BioUtah News | Tagged | Comments Off on CancerVax Announces Promising New Drug to Treat a Deadly Children’s Cancer

CancerVax Launches $5 Million Funding Round

Proceeds from the SEC qualified Reg A+ offering will allow the Company to continue work on its breakthrough cancer treatments

Posted in BioUtah News | Tagged | Comments Off on CancerVax Launches $5 Million Funding Round

CancerVAX Reports Significant Progress on Universal Cancer Vaccine Development at UCLA

Three separate teams of physician scientists at UCLA working on three different parts of the project have made significant progress and are ready to merge their work into a complete proof-of-concept vaccine construct

Posted in BioUtah News | Tagged | Comments Off on CancerVAX Reports Significant Progress on Universal Cancer Vaccine Development at UCLA

CancerVAX Reports Positive Progress on Kids Cancer Immunotherapy Treatment

UCLA research team has successfully created 7 pre-clinical monoclonal antibody candidates for targeting Ewing sarcoma

Posted in BioUtah News | Tagged | Comments Off on CancerVAX Reports Positive Progress on Kids Cancer Immunotherapy Treatment